Cyclooxygenase-2, prostaglandin E2, and microglial activation in prion diseases (Q28239508)

International Review of Neurobiology

Europe PubMed Central

title

Cyclooxygenase-2, prostaglandin E2, and microglial activation in prion diseases (English)

0 references

0 references

0 references

1 reference

Luisa Minghetti

1

0 references

Maurizio Pocchiari

object named as

Maurizio Pocchiari

series ordinal

2

0 references

language of work or name

English

0 references

publication date

2007

0 references

published in

0 references

volume

82

0 references

page(s)

265-75

0 references

cites work

Cyclo-oxygenase inhibitors protect against prion-induced neurotoxicity in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Evidence for an early inflammatory response in the central nervous system of mice with scrapie.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Cyclooxygenase 2 (COX-2) inhibition increases the inflammatory response in the brain during systemic immune stimuli

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Prostaglandin E2 and microsomal prostaglandin E synthase-2 expression are decreased in the cyclooxygenase-2-deficient mouse brain despite compensatory induction of cyclooxygenase-1 and Ca2+-dependent phospholipase A2.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Characterization of inducible cyclooxygenase in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Cyclooxygenase-2 regulates prostaglandin E2 signaling in hippocampal long-term synaptic plasticity

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Atypical antiinflammatory activation of microglia induced by apoptotic neurons: possible role of phosphatidylserine-phosphatidylserine receptor interaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Inflammatory response: pathway across the blood-brain barrier.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Coxibs and Alzheimer's disease: should they stay or should they go?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Prostaglandins and leukotrienes: advances in eicosanoid biology

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Neuronal apoptosis in Creutzfeldt-Jakob disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Early behavioural changes in scrapie-affected mice and the influence of dapsone

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Prostaglandins as modulators of immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Neuronal COX-2 expression and phosphorylation of pRb precede p38 MAPK activation and neurofibrillary changes in AD temporal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Maximal COX-2 and ppRb expression in neurons occurs during early Braak stages prior to the maximal activation of astrocytes and microglia in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Phenotypic variability in human prion diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Cyclooxygenase-2 expression during rat neocortical development and in Rett syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Acetaminophen and the cyclooxygenase-3 puzzle: sorting out facts, fictions, and uncertainties

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Regulation of prostanoid synthesis in microglial cells and effects of prostaglandin E2 on microglial functions.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Dapsone to delay symptoms in Creutzfeldt-Jakob disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Increased brain synthesis of prostaglandin E2 and F2-isoprostane in human and experimental transmissible spongiform encephalopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Increased CSF levels of prostaglandin E(2) in variant Creutzfeldt-Jakob disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Atypical inflammation in the central nervous system in prion disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

COX-2 inhibitors--lessons in drug safety

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Sporadic Creutzfeldt-Jakob disease: the extent of microglia activation is dependent on the biochemical type of PrPSc

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Cloning, expression, and functional characterization of human cyclooxygenase-1 splicing variants: evidence for intron 1 retention

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Intrahippocampal infusion of a cyclooxygenase-2 inhibitor attenuates memory acquisition in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Cognitive and neurological deficits induced by early and prolonged basal forebrain cholinergic hypofunction in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Postsynaptically synthesized prostaglandin E2 (PGE2) modulates hippocampal synaptic transmission via a presynaptic PGE2 EP2 receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Post-training intrahippocampal infusion of the COX-2 inhibitor celecoxib impaired spatial memory retention in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Microglia lacking E Prostanoid Receptor subtype 2 have enhanced Abeta phagocytosis yet lack Abeta-activated neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Photolabeling of Prostaglandin Endoperoxide H Synthase-1 with 3-Trifluoro-3-(m-Iiodophenyl)diazirine as a Probe of Membrane Association and the Cyclooxygenase Active Site

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Post-training cyclooxygenase-2 (COX-2) inhibition impairs memory consolidation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Intracellular-specific colocalization of prostaglandin E2 synthases and cyclooxygenases in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Cyclooxygenase-2 is highly expressed in microglial-like cells in a murine model of prion disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

A new variant of Creutzfeldt-Jakob disease in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Descriptive epidemiology of Creutzfeldt-Jakob disease in six European countries, 1993-1995. EU Collaborative Study Group for CJD.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021

Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2807%2982014-9

7 January 2021